Cheryl R. Blanchard - Mar 10, 2025 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Role
President, CEO, Director, Director
Signature
/s/ Cheryl R. Blanchard
Stock symbol
ANIK
Transactions as of
Mar 10, 2025
Transactions value $
-$97,576
Form type
4
Date filed
3/11/2025, 05:17 PM
Previous filing
Jun 7, 2024
Next filing
Mar 13, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIK Common Stock Options Exercise $0 +20K +13.09% $0.00 173K Mar 10, 2025 Direct F1, F2
transaction ANIK Common Stock Tax liability -$97.6K -5.87K -3.4% $16.62 167K Mar 10, 2025 Direct F3, F4
holding ANIK Common Stock 11.7K Mar 10, 2025 Revocable Trust F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIK Restricted Stock Unit Options Exercise $0 -20K -50% $0.00 20K Mar 10, 2025 Common Stock 20K $0.00 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the second vesting installment of RSUs granted on March 9, 2023.
F2 Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 800 shares purchased on May 14, 2024 and 330 shares purchased on November 14, 2024.
F3 Reflects an aggregate of 5,871 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2025.
F4 Reflects the closing price of ANIK common stock on March 7, 2025, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations.
F5 Consists of shares transferred by Dr. Blanchard to The Cheryl R. Blanchard Amended and Restated Revocable Trust dated December 19, 2014, of which Dr. Blanchard is a beneficiary and the sole trustee.
F6 Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024.